Lamotrigine

NDC 67877-166 · Ascend Laboratories, LLC

Generic nameLamotrigine

Dosage formTABLET

RouteORAL

Active ingredient(s)LAMOTRIGINE

Strength150 mg/1

Pharmacologic classAnti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]

Marketing categoryANDA

Packages

67877-166-60 — 60 TABLET in 1 BOTTLE (67877-166-60)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

65862-229 — Lamotrigine, 65862-230 — Lamotrigine, 65862-361 — Lamotrigine, 65862-362 — Lamotrigine, 67046-0358 — Lamotrigine, 67046-0359 — Lamotrigine, 67046-0749 — Lamotrigine, 67046-1573 — Lamotrigine, 67877-164 — Lamotrigine, 67877-165 — Lamotrigine, 67877-167 — Lamotrigine, 68071-3514 — Lamotrigine, 68071-3607 — LAMOTRIGINE, 68071-3944 — Lamotrigine, 68084-318 — Lamotrigine, 68084-319 — Lamotrigine, 68382-006 — Lamotrigine, 68382-007 — Lamotrigine, 68382-008 — Lamotrigine, 68382-009 — Lamotrigine, +270 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels